Literature DB >> 21343558

Can patient-reported outcome measures identify cancer patients' most bothersome issues?

Claire F Snyder1, Amanda L Blackford, Neil K Aaronson, Symone B Detmar, Michael A Carducci, Michael D Brundage, Albert W Wu.   

Abstract

PURPOSE: Patient-reported outcome (PRO) questionnaires are being investigated for their ability to aid in individual patient management. We evaluated whether PROs can identify patients' most bothersome quality-of-life issues and compared approaches for interpreting PRO scores.
METHODS: This secondary data analysis included 130 patients with cancer (mean age, 57 years; 71% female) receiving outpatient palliative chemotherapy. Patients completed a PRO (European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire [QLQ-C30]) at up to three consecutive visits and reported one or two of their most bothersome function and symptom issues from categories based on QLQ-C30 domains. We compared two approaches for interpreting PRO scores and identified which way better identified patients' most bothersome issues: worst scores in absolute terms or worst change from the previous time point.
RESULTS: For patients reporting one bothersome issue, absolute scores identified it correctly 91% of the time for both function and symptoms versus change scores' accuracy of 40% for function and 26% for symptoms. For patients reporting two bothersome issues, absolute scores identified at least one correctly 98% of the time for both function and symptoms versus change scores' 63% for function and 62% for symptoms. Absolute scores identified both issues correctly 42% of the time for function and 66% of the time for symptoms versus change scores' performance of 23% for both function and symptoms.
CONCLUSION: Absolute scores identify patients' most bothersome quality-of-life issues better than change scores. These results support the use of PROs in clinical practice and suggest that clinicians may want to focus on the worst absolute scores when examining PRO score reports.

Entities:  

Mesh:

Year:  2011        PMID: 21343558     DOI: 10.1200/JCO.2010.33.2080

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  17 in total

1.  Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs.

Authors:  Claire F Snyder; Amanda L Blackford; Jonathan Sussman; Daryl Bainbridge; Doris Howell; Hsien Y Seow; Michael A Carducci; Albert W Wu
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

2.  Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic.

Authors:  Sang-Yeon Suh; Thomas W Leblanc; Rebecca A Shelby; Gregory P Samsa; Amy P Abernethy
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

3.  Evaluating a new methodology for providing individualized feedback in healthcare on quality of life and its importance, using the WHOQOL-BREF in a community population.

Authors:  Alison M Llewellyn; Suzanne M Skevington
Journal:  Qual Life Res       Date:  2015-09-14       Impact factor: 4.147

4.  Interpreting and Acting on PRO Results in Clinical Practice: Lessons Learned From the PatientViewpoint System and Beyond.

Authors:  Amanda L Blackford; Albert W Wu; Claire Snyder
Journal:  Med Care       Date:  2019-05       Impact factor: 2.983

5.  Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial.

Authors:  Michael J Hassett; Sandra Wong; Raymond U Osarogiagbon; Jessica Bian; Don S Dizon; Hannah Hazard Jenkins; Hajime Uno; Christine Cronin; Deborah Schrag
Journal:  Trials       Date:  2022-06-16       Impact factor: 2.728

6.  Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention.

Authors:  Claire F Snyder; Amanda L Blackford; Toru Okuyama; Tatsuo Akechi; Hiroko Yamashita; Tatsuya Toyama; Michael A Carducci; Albert W Wu
Journal:  Qual Life Res       Date:  2013-03-27       Impact factor: 4.147

7.  Using patient-reported outcome measures to deliver enhanced supportive care to people with lung cancer: feasibility and acceptability of a nurse-led consultation model.

Authors:  Grigorios Kotronoulas; Constantina Papadopoulou; Mhairi F Simpson; John McPhelim; Lynn Mack; Roma Maguire
Journal:  Support Care Cancer       Date:  2018-05-19       Impact factor: 3.603

8.  PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study.

Authors:  Heike Schmidt; Daniela Merkel; Michael Koehler; Hans-Henning Flechtner; Jörg Sigle; Bernd Klinge; Karin Jordan; Dirk Vordermark; Margarete Landenberger; Patrick Jahn
Journal:  Support Care Cancer       Date:  2015-12-16       Impact factor: 3.603

9.  Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).

Authors:  Patrizia Maria Carrieri; Laurent Michel; Caroline Lions; Julien Cohen; Muriel Vray; Marion Mora; Fabienne Marcellin; Bruno Spire; Alain Morel; Perrine Roux
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

10.  Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.

Authors:  Johannes M Giesinger; Wilma Kuijpers; Teresa Young; Krzysztof A Tomaszewski; Elizabeth Friend; August Zabernigg; Bernhard Holzner; Neil K Aaronson
Journal:  Health Qual Life Outcomes       Date:  2016-06-07       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.